Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies

J Am Coll Surg. 2001 Feb;192(2):196-214. doi: 10.1016/s1072-7515(00)00791-2.

Authors

M J Silverstein¹, R Parker, J C Grotting, R J Cote, C A Russell

Affiliation

¹ Keck School of Medicine, University of Southern California, Los Angeles, USA.

PMID: 11220720
DOI: 10.1016/s1072-7515(00)00791-2

No abstract available

MeSH terms

Antineoplastic Agents, Hormonal / adverse effects
Antineoplastic Agents, Hormonal / therapeutic use
Axilla
Biopsy / instrumentation
Biopsy / methods
Breast Neoplasms / diagnosis*
Breast Neoplasms / therapy*
Carcinoma, Intraductal, Noninfiltrating / diagnosis*
Carcinoma, Intraductal, Noninfiltrating / therapy*
Combined Modality Therapy
Female
Hormone Replacement Therapy / adverse effects
Humans
Lymphatic Metastasis
Mammaplasty / methods
Mastectomy / methods
Mastectomy / rehabilitation
Neoplasm Recurrence, Local
Risk Factors
Tamoxifen / adverse effects
Tamoxifen / therapeutic use

Substances

Antineoplastic Agents, Hormonal
Tamoxifen